Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shisanwei Hezhong Pill (also known as Shisanwei Hezhong Wan or Thirteen Flavors and Middle Pill) is a Traditional Chinese Medicine (TCM) formulation developed by the Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine. It is specifically designed for the treatment of functional dyspepsia, a condition involving chronic indigestion and abdominal discomfort. The formula is based on the academic heritage of renowned Chinese medicine practitioners specializing in spleen and stomach diseases. Its therapeutic approach focuses on harmonizing the middle (Hezhong), a TCM principle aimed at regulating the digestive functions of the spleen and stomach to alleviate symptoms such as bloating, epigastric pain, and early satiety. The pill is currently undergoing clinical evaluation to establish its efficacy and safety profile in patients with functional dyspepsia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shisanwei hezhong pill.